U.S. life expectancy rose by 0.1 year in 2018 to 78.7, the Centers for Disease Control and Prevention reported last week. Among specific improvements, the drug overdose death rate fell by 4.6% overall, to 20.7 per 100,000; and the infant mortality rate fell by 2.3%, to 566.2 per 100,000 live births. Death rates also decreased 2.9% for chronic lower respiratory diseases, 2.8% for unintentional injuries, 2.2% for cancer, 1.6% for Alzheimer disease, 1.3% for stroke, and 0.8% for heart disease; and increased 4.2% for flu and pneumonia and 1.4% for suicide.

“In 2018, for the first time in more than two decades, fewer Americans died of drug overdoses than the year before, and for the first time in four years, American life expectancy rose,” said Health and Human Services Secretary Alex Azar. “This news is a real victory, and it should be a source of encouragement for all Americans who have been committed to connecting people struggling with substance abuse to treatment and recovery.” 
 

Chairperson's File
Public
Hospitals and health systems — traditionally focused on acute care — are increasingly becoming more involved in primary care. There is tremendous value for…
Headline
The deadline to apply for the inaugural AHA Age-Friendly Healthcare Impact Award is Sept. 25. The award, created by the AHA and The John A. Hartford Foundation…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…
Headline
There are now 17,180 confirmed cases of cyclosporiasis in the U.S., the Centers for Disease Control and Prevention reported Aug. 25. At least 11,844 additional…
Headline
The Food and Drug Administration has approved a blood test for detecting Alzheimer’s by Roche and Eli Lilly, according to an announcement Aug. 24 by Roche. The…
Headline
There have been 15,716 confirmed cases of cyclosporiasis across 47 states, Washington, D.C., and Puerto Rico since May 1, the Centers for Disease Control and…